Cardlytics
CDLX
132 hedge funds and large institutions have $297M invested in Cardlytics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 26 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 38
0.32% more ownership
Funds ownership: 9.29% → 9.61% (+0.32%)
4% less funds holding
Funds holding: 138 → 132 (-6)
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
58% less capital invested
Capital invested by funds: $706M → $297M (-$409M)
75% less call options, than puts
Call options by funds: $3.39M | Put options by funds: $13.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GEH
General Equity Holdings
Brooklyn,
New York
|
+$9.16M |
| 2 |
Two Sigma Advisers
New York
|
+$5.69M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.85M |
| 4 |
Two Sigma Investments
New York
|
+$3.55M |
| 5 |
6CM
683 Capital Management
New York
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$16M |
| 2 |
Jennison Associates
New York
|
-$9.78M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$8.62M |
| 4 |
OCP
Oakcliff Capital Partners
New York
|
-$7.58M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$6.69M |
CDLX Hedge Fund Activity: Q3 2022 in Review
132 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2022, worth a combined $297M — down 58% from $706M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CDLX and 20 opened new positions — a net loss of 6 holders — while 38 trimmed existing stakes and 50 added.
The largest buyer was General Equity Holdings, opening a new position worth an estimated $9.16M. The largest seller was Ameriprise, exiting entirely with an estimated $16M sold.
- 132 institutional investors held Cardlytics (CDLX) as of Q3 2022, down from 138 in Q2 2022.
- Funds reported $297M of Cardlytics stock for Q3 2022, down 58% quarter-over-quarter.
- 20 funds opened new Cardlytics positions in Q3 2022 and 26 closed out, a net change of -6 holders.
- The largest Cardlytics buyer in Q3 2022 was General Equity Holdings, an estimated $9.16M added.
- The largest Cardlytics seller in Q3 2022 was Ameriprise, an estimated $16M sold.
Based on aggregated 13F filings for Q3 2022.